Technical Analyst, Sudarshan Sukhani expects Ranbaxy to witness a doubling of prices from current levels.
Sukhani told CNBC-TV18, "Ranbaxy is in an uptrend, it is in a bull market of its own. The idea should be that every dip whenever the market corrects and the stock corrects it should be a buying opportunity. We are going to see a doubling of prices from current levels. A time is of course a factor but it is a quite strong probability."
Source: Moneycontrol.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment